FDA Approved: WELIREG — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA granted original approval for Welireg (belzutifan) from Merck Sharp & Dohme LLC for von Hippel-Lindau disease–associated tumors including renal cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Hippel-lindau Disease-associated Central Nervous System Hemangioblastomas
• Von Hippel-lindau Disease-associated Pancreatic Neuroendocrine Tumor
• Von Hippel-lindau Disease-associated Renal Cell Carcinoma

Drugs mentioned

• Welireg (belzutifan)

Snippet

ORIG AP for WELIREG (BELZUTIFAN)